Literature DB >> 19220757

Purinergic contribution to small intestinal afferent hypersensitivity in a murine model of postinfectious bowel disease.

W Rong1, C Keating, B Sun, L Dong, D Grundy.   

Abstract

Increased sensitivity of the afferent innervation of the gastrointestinal tract reportedly underlies symptoms of discomfort and pain in functional bowel disorders. The present investigation aimed to examine whether the purinergic P2X(2) and P2X(3) receptor subunits contribute to the mechanosensitivity of small intestinal afferents in normal mice and in a murine model of postinfectious gut dysfunction. Mesenteric afferent nerve activity was recorded in a mouse jejunum preparation maintained in vitro. As has been shown previously, ramp distension of the jejunal segment evoked biphasic afferent discharge, reflecting activation of low and high threshold fibres. The average pressure-afferent response curve in mice deficient in both P2X(2) and P2X(3) subunits (n = 14) was not significantly different from that of the wild-type control preparations (n = 13). Application of pyridoxal 5-phosphate 6-azophenyl-2 ,4-disulphonic acid (PPADS) (30 micromol L(-1)), a P2X and P2Y antagonist, or 2,4,6-trinitrophenol-adenosine 5'-triphosphate (10 micromol L(-1)), an antagonist selective for homomeric P2X(3) and heteromeric P2X(2/3) receptors, had no effect on the averaged pressure-afferent response curve in wild-type animals. In Trichinella spiralis-infected mice, the magnitude of mesenteric afferent responses to jejunal distension was greater at day 21 and day 56 postinfection compared with the sham control preparations demonstrating the development of afferent hypersensitivity. PPADS had no significant effect upon mechanically evoked afferent discharge rates in sham treated preparations (n = 5), but significantly inhibited afferent sensitivity to jejunal distension in preparations from mice at day 21 (n = 6) and day 56 (n = 7) postinfection. These results suggest that purinergic mechanisms play no role in mechanosensory transduction in the normal small intestine but contribute significantly to postinfectious mechano-hypersensitivity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19220757     DOI: 10.1111/j.1365-2982.2008.01259.x

Source DB:  PubMed          Journal:  Neurogastroenterol Motil        ISSN: 1350-1925            Impact factor:   3.598


  8 in total

Review 1.  Potential for developing purinergic drugs for gastrointestinal diseases.

Authors:  Fernando Ochoa-Cortes; Andromeda Liñán-Rico; Kenneth A Jacobson; Fievos L Christofi
Journal:  Inflamm Bowel Dis       Date:  2014-07       Impact factor: 5.325

Review 2.  The roles of purinergic signaling during gastrointestinal inflammation.

Authors:  Jane A Roberts; Mark K Lukewich; Keith A Sharkey; John B Furness; Gary M Mawe; Alan E Lomax
Journal:  Curr Opin Pharmacol       Date:  2012-10-11       Impact factor: 5.547

3.  Peripheral and central P2X receptor contributions to colon mechanosensitivity and hypersensitivity in the mouse.

Authors:  Masamichi Shinoda; Bin Feng; G F Gebhart
Journal:  Gastroenterology       Date:  2009-06-21       Impact factor: 22.682

Review 4.  Purinergic signalling in the gastrointestinal tract and related organs in health and disease.

Authors:  Geoffrey Burnstock
Journal:  Purinergic Signal       Date:  2013-12-04       Impact factor: 3.765

5.  P2Y Receptors Sensitize Mouse and Human Colonic Nociceptors.

Authors:  James R F Hockley; Michael M Tranter; Cian McGuire; George Boundouki; Vincent Cibert-Goton; Mohamed A Thaha; L Ashley Blackshaw; Gregory J Michael; Mark D Baker; Charles H Knowles; Wendy J Winchester; David C Bulmer
Journal:  J Neurosci       Date:  2016-02-24       Impact factor: 6.167

6.  In pursuit of P2X3 antagonists: novel therapeutics for chronic pain and afferent sensitization.

Authors:  Anthony P Ford
Journal:  Purinergic Signal       Date:  2011-11-18       Impact factor: 3.765

7.  P2X3 receptors mediate visceral hypersensitivity during acute chemically-induced colitis and in the post-inflammatory phase via different mechanisms of sensitization.

Authors:  Annemie Deiteren; Laura van der Linden; Anouk de Wit; Hannah Ceuleers; Roeland Buckinx; Jean-Pierre Timmermans; Tom G Moreels; Paul A Pelckmans; Joris G De Man; Benedicte Y De Winter
Journal:  PLoS One       Date:  2015-04-17       Impact factor: 3.240

8.  Vitamin B6 deficiency and diseases in elderly people--a study in nursing homes.

Authors:  Ida K Kjeldby; Gunvor S Fosnes; Solveig C Ligaarden; Per G Farup
Journal:  BMC Geriatr       Date:  2013-02-08       Impact factor: 3.921

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.